Our patients can schedule a COVID-19 vaccination through NYU Langone Health MyChart or the NYU Langone Health app. Learn more about the COVID-19 vaccine. Read our updated information about wearing a mask for your visit, and our visitor policy.

If you need help accessing our website, call 855-698-9991
Skip to main content
Theresa Ryan at [NYU Langone Health]
NYU Langone Provider

Theresa Ryan, MD

NYU Langone Provider
  • Specialty: Medical Oncology
  • Treats: Adults
  • Language: English

Conditions and Treatments

For Adults
Conditions
  • abdominal tumor
  • colorectal cancer
  • gallbladder cancer
Treatments
  • bloodless medicine
Learn more about conditions we treat at NYU Langone:
Liver Cancer & Liver Metastases , Stomach Cancer , Colorectal Cancer

Positions
Board Certifications
  • American Board of Preventive Medicine (Clinical Informatics), 2022
  • American Board of Internal Medicine (Medical Oncology), 2003
Education and Training
  • Fellowship, New York University School of Medicine, Hematology Oncology, 2003
  • Residency, New York University School of Medicine, Medicine, 2000
  • MD from New York University, 1996

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Aetna
     
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Agewell
     
    • Agewell
  • Amidacare
     
    • Amidacare
  • Centerlight
     
    • Centerlight
  • Cigna
     
    • Cigna EPO/POS
    • Cigna PPO
  • ElderPlan
     
    • ElderPlan
  • Emblem
     
    • Emblem Select Care Exchange
  • Empire Blue Cross Blue Shield
     
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield HealthPlus
    • Empire Blue Cross Blue Shield HealthPlus Essential
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
  • Fidelis
     
    • Fidelis Child Health
    • Fidelis Essential
    • Fidelis Exchange
    • Fidelis Medicaid
    • Fidelis Medicare
  • GHI
     
    • GHI CBP
    • GHI HMO
  • HIP
     
    • HIP Access I
    • HIP Access II
    • HIP Child Health
    • HIP EPO/PPO
    • HIP Essential
    • HIP HMO
    • HIP Medicaid
    • HIP Medicare
    • HIP POS
View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

  • A Phase 2 Clinical Study of TJ004309 in Combination With Atezolizumab (TECENTRIQ ) in Patients With Advanced or Metastatic Ovarian Cancers and Selected Advanced Solid Tumors

    Learn More

  • A Phase 1b Multicenter Study to Determine the Dose Safety Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.

    Learn More

  • A Phase Ib/II Multicenter Open-label Modular Dose-Finding and Dose Expansion Study to Explore the Safety Tolerability and Anti-tumor Activity of Trastuzumab Deruxtecan (DS-8201a T-DXd) in Combination with other Anti-cancer Agents in Patients with Metastatic HER2-positive Breast Cancer (DESTINY-Breast07)

    Learn More
View All Research Studies (8)

Read All Publications (24)